• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型β-环糊精-大黄酸缀合物,用于提高大黄酸的水溶性和生物利用度。

A novel β-cyclodextrin-rhein conjugate for improving the water solubility and bioavailability of rhein.

机构信息

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.

出版信息

Carbohydr Res. 2020 Apr;490:107958. doi: 10.1016/j.carres.2020.107958. Epub 2020 Feb 19.

DOI:10.1016/j.carres.2020.107958
PMID:32120022
Abstract

Rhein is a potential antitumor agent, but the poor water-solubility restricts its clinical applicability. β-cyclodextrin-drug conjugates provide a possibility to improve the water-solubility of rhein and thereby enhance its bioavailability. A novel β-cyclodextrin-rhein conjugate (β-CD-RH) was synthesized by covalently link β-cyclodextrin with rhein through a 1,8-diamino-3,6-dioxaoctane linker. The structure of β-CD-RH was characterized by H NMR, FT-IR, Maldi-tof MS etc. The inclusion style of β-CD-RH in water was detected by 2D NMR. The 2D ROESY spectrum provided details of the rhein moiety encapsulated in the β-CD cavity. The water-solubility of β-CD-RH is up to 3.24 μmol/mL β-CD-RH exhibited higher cytotoxicity than rhein and rhein/β-CD mixture against Hela cells. Our work provides a new way for the preparation of novel β-CD-drug conjugate.

摘要

大黄酸是一种有潜力的抗肿瘤药物,但较差的水溶性限制了其临床应用。β-环糊精-药物缀合物为提高大黄酸的水溶性,从而提高其生物利用度提供了可能。通过 1,8-二氨基-3,6-二氧辛烷连接子将β-环糊精与大黄酸共价连接,合成了一种新型的β-环糊精-大黄酸缀合物(β-CD-RH)。通过 1 H NMR、FT-IR、Maldi-tof MS 等方法对 β-CD-RH 的结构进行了表征。通过二维 NMR 检测了β-CD-RH 在水中的包合方式。二维 ROESY 谱图提供了大黄酸部分被包裹在β-CD 腔中的详细信息。β-CD-RH 的水溶性高达 3.24μmol/mL,β-CD-RH 对 Hela 细胞的细胞毒性高于大黄酸和大黄酸/β-CD 混合物。我们的工作为新型β-CD-药物缀合物的制备提供了一种新方法。

相似文献

1
A novel β-cyclodextrin-rhein conjugate for improving the water solubility and bioavailability of rhein.一种新型β-环糊精-大黄酸缀合物,用于提高大黄酸的水溶性和生物利用度。
Carbohydr Res. 2020 Apr;490:107958. doi: 10.1016/j.carres.2020.107958. Epub 2020 Feb 19.
2
Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex.大黄酸/环糊精包合物的溶解性能、光谱性质和光稳定性。
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Dec;74(5):1254-9. doi: 10.1016/j.saa.2009.09.056. Epub 2009 Oct 6.
3
[Preparation, characterization and antitumor of cyclodextrin inclusion of an anti-cancer drug regorafenib].[抗癌药物瑞戈非尼环糊精包合物的制备、表征及抗肿瘤作用]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Mar 25;46(2):144-152. doi: 10.3785/j.issn.1008-9292.2017.04.05.
4
Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics.基于低分子量壳聚糖的雷因口服传递缀合物的合成、表征及药代动力学研究。
Drug Dev Ind Pharm. 2019 Jan;45(1):96-104. doi: 10.1080/03639045.2018.1522326. Epub 2018 Sep 26.
5
Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.厄洛替尼与磺丁基醚-β-环糊精包合物的制备、表征、体内外评价。
Carbohydr Polym. 2015 Dec 10;134:547-56. doi: 10.1016/j.carbpol.2015.08.012. Epub 2015 Aug 12.
6
Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: phase solubility and spectroscopic methods.氯霉素与七(2,6-二-O-甲基)-β-环糊精的包合相互作用:相溶解度和光谱法研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2011 Dec;83(1):570-4. doi: 10.1016/j.saa.2011.09.005. Epub 2011 Sep 10.
7
Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.丁香酚羟丙基-β-环糊精包合物的制备与表征:差分脉冲伏安法和核磁共振氢谱
Chem Pharm Bull (Tokyo). 2010 Oct;58(10):1313-9. doi: 10.1248/cpb.58.1313.
8
Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.氯唑沙宗与β-环糊精和羟丙基-β-环糊精包合物的研究:特性、溶解和细胞毒性。
Carbohydr Polym. 2015 Oct 20;131:297-305. doi: 10.1016/j.carbpol.2015.05.055. Epub 2015 Jun 4.
9
Host-guest inclusion system of rhein with polyamine-modified β-cyclodextrins: characterization and cytotoxicity.雷因与多胺修饰的β-环糊精的主体-客体包合体系:表征和细胞毒性。
Pharm Dev Technol. 2017 Aug;22(5):669-677. doi: 10.1080/10837450.2016.1221429. Epub 2016 Aug 30.
10
Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin.泊沙康唑与β-环糊精和2,6-二-O-甲基-β-环糊精复合物的表征及体外评价
AAPS PharmSciTech. 2017 Jan 1;18(1):104-114. doi: 10.1208/s12249-016-0497-z. Epub 2016 Feb 16.

引用本文的文献

1
Gold nanocomposites in colorectal cancer therapy: characterization, selective cytotoxicity, and migration inhibition.用于结直肠癌治疗的金纳米复合材料:表征、选择性细胞毒性及迁移抑制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 29. doi: 10.1007/s00210-025-03839-z.
2
Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications.大黄酸:关于其生物活性、药代动力学、结构优化及未来药物应用的最新综述
Pharmaceuticals (Basel). 2024 Dec 10;17(12):1665. doi: 10.3390/ph17121665.
3
Utilization of carbon catabolite repression for efficiently biotransformation of anthraquinone O-glucuronides by DM.
利用碳代谢物阻遏作用实现DM对蒽醌O-葡萄糖醛酸苷的高效生物转化。
Front Microbiol. 2024 Apr 16;15:1393073. doi: 10.3389/fmicb.2024.1393073. eCollection 2024.
4
Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.纳米技术在肾小球肾炎治疗中的应用:现状与展望。
J Nanobiotechnology. 2024 Jan 3;22(1):9. doi: 10.1186/s12951-023-02257-8.
5
The mechanism of traditional medicine in alleviating ulcerative colitis: regulating intestinal barrier function.传统医学缓解溃疡性结肠炎的机制:调节肠道屏障功能。
Front Pharmacol. 2023 Oct 9;14:1228969. doi: 10.3389/fphar.2023.1228969. eCollection 2023.
6
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes.将贝达喹啉重新用于有效的非小细胞肺癌(NSCLC)治疗:作为可吸入环糊精基分子包合物。
Int J Mol Sci. 2021 Apr 30;22(9):4783. doi: 10.3390/ijms22094783.